Literature DB >> 22190719

The human adenovirus type 5 E1B 55-kilodalton protein is phosphorylated by protein kinase CK2.

Wilhelm Ching1, Thomas Dobner, Emre Koyuncu.   

Abstract

The human adenovirus type 5 (HAdV5) early region 1B 55-kDa protein (E1B-55K) is a multifunctional phosphoprotein playing several critical roles during adenoviral productive infection, e.g., degradation of host cell proteins, viral late mRNA export, and inhibition of p53-mediated transcription. Many of these functions are apparently regulated at least in part by the phosphorylation of E1B-55K occurring at a stretch of amino acids resembling a potential CK2 consensus phosphorylation motif. We therefore investigated the potential role of CK2 phosphorylation upon E1B-55K during adenoviral infection. A phosphonegative E1B-55K mutant showed severely reduced virus progeny production, although viral early, late, and structural protein levels and viral DNA replication were not obviously affected. Binding studies revealed an interaction between the CK2α catalytic subunit and wild-type E1B-55K, which is severely impaired in the phosphonegative E1B mutant. In addition, in situ the α-catalytic subunit is redistributed into ring-like structures surrounding E1B-55K nuclear areas and distinct cytoplasmic accumulations, where a significant amount of CK2α colocalizes with E1B-55K. Furthermore, in in vitro phosphorylation assays, wild-type E1B-55K glutathione S-transferase fusion proteins were readily phosphorylated by the CK2α subunit but inefficiently phosphorylated by the CK2 holoenzyme. Addition of the CK2-specific inhibitors TBB (4,5,6,7-tetrabromobenzotriazole) and DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole) to infected cells confirmed that CK2α binding to E1B-55K is necessary for efficient phosphorylation of E1B-55K. In summary, our data show that CK2α interacts with and phosphorylates HAdV5 E1B-55K at residues S490/491 and T495 and that these posttranslational modifications are essential for E1B-55K lytic functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190719      PMCID: PMC3302271          DOI: 10.1128/JVI.06066-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

Review 1.  Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.

Authors:  Andrew N Blackford; Roger J A Grand
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

2.  Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis.

Authors:  Mauro Salvi; Stefania Sarno; Luca Cesaro; Hideji Nakamura; Lorenzo A Pinna
Journal:  Biochim Biophys Acta       Date:  2009-01-31

3.  Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex.

Authors:  Frédéric Dallaire; Paola Blanchette; Peter Groitl; Thomas Dobner; Philip E Branton
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

4.  Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport.

Authors:  L E Babiss; H S Ginsberg; J E Darnell
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

5.  Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products.

Authors:  E Harlow; B R Franza; C Schley
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

6.  Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue.

Authors:  U Münstermann; G Fritz; G Seitz; Y P Lu; H R Schneider; O G Issinger
Journal:  Eur J Biochem       Date:  1990-04-30

Review 7.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

Review 8.  Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival.

Authors:  N A St-Denis; D W Litchfield
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

9.  Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression.

Authors:  Jan Chemnitz; Dorothea Pieper; Cordula Grüttner; Joachim Hauber
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

10.  The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs.

Authors:  S Pilder; M Moore; J Logan; T Shenk
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

View more
  5 in total

Review 1.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

2.  Aggresome formation by the adenoviral protein E1B55K is not conserved among adenovirus species and is not required for efficient degradation of nuclear substrates.

Authors:  Paola Blanchette; Peter Wimmer; Frédéric Dallaire; Chi Ying Cheng; Philip E Branton
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 3.  Viral Interplay with the Host Sumoylation System.

Authors:  Van G Wilson
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  A ubiquitin-specific protease possesses a decisive role for adenovirus replication and oncogene-mediated transformation.

Authors:  Wilhelm Ching; Emre Koyuncu; Sonia Singh; Christina Arbelo-Roman; Barbara Hartl; Elisabeth Kremmer; Thomas Speiseder; Chris Meier; Thomas Dobner
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

5.  Protein-Protein Interactions Facilitate E4orf6-Dependent Regulation of E1B-55K SUMOylation in HAdV-C5 Infection.

Authors:  Marie Fiedler; Wing-Hang Ip; Helga Hofmann-Sieber; Britta Wilkens; Francis K Nkrumah; Wenli Zhang; Anja Ehrhardt; Luca D Bertzbach; Thomas Dobner
Journal:  Viruses       Date:  2022-02-24       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.